Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a quick chat in the Doctor's office prevent youth overdoses?

NCT ID NCT07022717

Prevention Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 5 times

Summary

This pilot study tests whether a brief overdose prevention education, including naloxone training, is feasible and acceptable for youth ages 13-26 during routine primary care visits. Providers will deliver the intervention to some youth, while others receive usual care. The study aims to see if this approach can be implemented in real-world clinics and whether youth find it helpful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Brief overdose prevention education and naloxone information
What this could lead to
If successful, this could lead to a scalable, evidence-based overdose prevention program for youth in primary care settings.
What could go wrong
This is a very small pilot study (24 participants) focused on feasibility, not effectiveness. It may not show a reduction in overdose rates or be generalizable beyond this single center.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Aug 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for providers: * Physicians and advance practice providers within Pediatric Primary Care and Family Medicine at Boston Medical Center (BMC) * ≥ 2 clinic sessions per/week Exclusion Criteria for providers: * None Inclusion criteria for youth: * Ages 13-26 * Scheduled for a comprehensive physical exam with a provider who is participating in the trial * English speaking Exclusion criteria for youth: * Caregivers of youth ages 13-17 unable to provide informed consent or are not English speaking * Cognitive limitation or intellectual disability that in the opinion of their provider would not * Any medical/psychiatric condition that causes acute distress and requires emergency evaluation * Under legal custody of the Department of Children and Families (DCF)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overdose are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Drug Overdose poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overdose

Contacts and locations

Locations

  • Boston Medical Center, Pediatric Primary Care & Family Medicine

    Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.